Stocks Explorer
Stocks
Sectors
Search
Day One Biopharmaceuticals, Inc.(DAWN) News
Profile
Chart
News
Analysis
Holders
DAWN price today
by TradingView
Date
Title
Sep 12
Day One Announces Updated FIREFLY-1 Data for Tovorafenib and Completion of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)
Apr 26
Day One Announces Abstracts Accepted for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
‹ Prev
Page
of 2
Next ›